Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer
deerfield management
detroit blog main
detroit top stories
europe blog main
europe top stories
fda
gilead sciences
indiana blog main
indiana top stories
ipo
life sciences
melinta therapeutics
national
national blog main
national top stories
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
venture capital
wisconsin blog main
wisconsin top stories
abbvie
accent therapeutics
What
bio
covid
2
×
ipo
2
×
medicines
roundup
acquisitions
activity
announced
approvals
biogen
ceo
clamped
collabs
daniel
deal
delays
developing
economic
fast
fda
gilead
gilead’s
help
including
introduce
isn’t
lot
month
new
oric’s
o’day
plans
sciences
showing
spread
testing
transformative
work
years
Language
unset
Current search:
ipo
×
covid
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
